Mammary adenocarcinomas in three male cats exposed to medroxyprogesterone acetate (1990-2006)

Journal of Feline Medicine and Surgery

Volumn 12, Issue 2, 2010, Pages 169-174

  Jacobs, Terry M ^a   Hoppe, Bruce R ^a   Poehlmann, Cathy E ^a   Ferracone, Jackie D ^b   Sorenmo, Karin U ^c  

^a Park Pet Hospital   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADENOCARCINOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; CAT; CAT DISEASE; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL NEOPLASM; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY;

ADENOCARCINOMA; ANIMALS; CAT DISEASES; CATS; IMMUNOHISTOCHEMISTRY; MALE; MAMMARY NEOPLASMS, ANIMAL; MEDROXYPROGESTERONE ACETATE;

FELIDAE;

EID: 75149154588     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2009.08.004     Document Type: Article

References (33)

1. Plumb D.C. Medroxyprogesterone acetate. Veterinary drug handbook. 5th edn (2005), Pharmavet, Stockholm, WI
2. Moore A.S., and Ogilvie G.K. Mammary tumors. In: Ogilvie G.K., and Moore A.S. (Eds). Feline oncology, a comprehensive guide to compassionate care (2001), Veterinary Learning Systems, Trenton
3. Hayden D., Johnston S., Kiang D., Johnson K., and Barnes D. Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects. Am J Vet Res 42 (1981) 1699-1703
4. McAloose D., Munson L., and Naydan D.K. Histologic features of mammary carcinoma in zoo felids treated with melengestrol acetate (MGA) contraceptives. Vet Pathol 44 (2007) 320-326
5. Hernandez F.J., Fernandez B.B., Chertack M., and Gage P.A. Feline mammary carcinoma and progestogens. Feline Pract 5 (1975) 45-48
6. Loretti A.P., Ilha M.R., Ordas J., and Martin de las Mulas J. Clinical, pathological and immunohistochemical study of feline mammary fibroepithelial hyperplasia following a single injection of depot medroxyprogesterone acetate. J Fel Med Surg 7 (2005) 43-52
7. Misdorp W. Progestagens and mammary tumours in dogs and cats. Acta Endocrinol (Copenh) 125 suppl 1 (1991) 27-31
8. Skorupski K.A., Overley B., Shofer F.S., Goldschmidt M.H., Miller C.A., and Sorenmo K.U. Clinical characteristics of mammary carcinoma in male cats. J Vet Intern Med 19 (2005) 52-55
9. Mol J.A., van Garderen E., Rutteman G.R., and Rijnberk A. New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary gland of dogs, cats and humans. J Steroid Biochem Mol Biol 57 (1996) 67-71
10. Rijnberk A., and Mol J.A. Progestin-induced hypersecretion of growth hormone: an introductory review. J Reprod Fertil Suppl 51 (1997) 335-338
11. van Garderen E., de Wit M., Voorhout W.F., et al. Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop. Am J Pathol 150 (1997) 1037-1047
12. Overley B., Shofer F.S., Goldschmidt M.H., Sherer D., and Sorenmo K.U. Association between ovariohysterectomy and feline mammary carcinoma. J Vet Intern Med 19 (2005) 560-563
13. Misdorp Wz, Else RW, Hellman E, Lipscomb TP. Histologic classification of mammary tumors of the dog and cat. Vol. 7: Washington DC: Armed Forces Institute of Pathology, 1999: 58.
14. Hayden D.W., Barnes D.M., and Johnson K.H. Morphologic changes in the mammary gland of megestrol acetate-treated and untreated cats: a retrospective study. Vet Pathol 26 (1989) 104-113
15. MacEwen E.G., Hayes A.A., Harvey H.J., et al. Prognostic factors for feline mammary tumors. J Am Vet Med Assoc 185 (1984) 201-204
16. Viste J.R., Myers S.L., Singh B., and Simko E. Feline mammary adenocarcinoma: tumor size as a prognostic indicator. Can Vet J 43 (2002) 33-37
17. Castagnaro M., Casalone C., Bozzetta E., De Maria R., Biolatti B., and Caramelli M. Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas. J Comp Pathol 119 (1998) 263-275
18. Ito T., Kadosawa T., Mochizuki M., Matsunaga S., Nishimura R., and Sasaki N. Prognosis of malignant mammary tumor in 53 cats. J Vet Med Sci 58 (1996) 723-726
19. Castagnaro M., Casalone C., Ru G., Nervi G.C., Bozzetta E., and Caramelli M. Argyrophilic nucleolar organizer regions (AgNORs) count as indicator of post-surgical prognosis in feline mammary carcinomas. Res Vet Sci 64 (1998) 97-100
20. Castagnaro M., De Maria R., Bozzetta E., et al. Ki-67 index as an indicator of the post-surgical prognosis in feline mammary carcinomas. Res Vet Sci 65 (1998) 223-226
21. Millanta F., Lazzeri G., Vannozzi I., Viacava P., and Poli A. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas. Vet Pathol 39 (2002) 690-696
22. Murakami Y., Tateyama S., Rungsipipat A., Uchida K., and Yamaguchi R. Amplification of the cyclin a gene in canine and feline mammary tumors. J Vet Med Sci 62 (2000) 783-787
23. Winston J., Craft D.M., Scase T.J., and Bergman P.J. Immunohistochemical detection of HER-2/neu expression in spontaneous feline mammary tumours. Vet Comp Oncol 3 (2005) 8-15
24. Jeglum K.A., de Guzman E., and Young K.M. Chemotherapy of advanced mammary adenocarcinoma in 14 cats. J Am Vet Med Assoc 87 (1985) 157-160
25. Novosad C.A., Bergman P.J., O'Brien M.G., et al. Retrospective evaluation of adjunctive doxorubicin for the treatment of feline mammary gland adenocarcinoma: 67 cases. J Am Anim Hosp Assoc 42 (2006) 110-120
26. McNeil C.J., Sorenmo K.U., Shofer F.S., et al. Evaluation of adjuvant doxorubici-based chemotherapy for the treatment of feline mammary carcinoma. J Vet Intern Med 23 (2009) 123-129
27. Munson L., and Moresco A. Comparative pathology of mammary gland cancers in domestic and wild animals. Breast Dis 28 (2007) 7-21
28. Johnston S.H., Hayden D.W., Kiang D.T., Handschin B., and Johnson K.H. Progesterone receptors in feline mammary adenocarcinoma. Am J Vet Res 45 (1984) 379-382
29. Millanta F., Calandrella M., Bari G., Niccolini M., Vannozzi I., and Poll A. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Res Vet Sci 79 (2005) 225-232
30. Hart B.L. Objectionable urine spraying and urine marking in cats: evaluation of progestin treatment in gonadectomized males and females. J Am Vet Med Assoc 177 (1980) 529-533
31. Lana S.E., Rutteman G.R., and Withrow S.J. Tumors of the mammary gland. In: Withrow S.J., and Vail D.M. (Eds). Small animal clinical oncology. 4th edn (2007), Saunders Elsevier, St Louis
32. Molinolo A.A., Lanari C., Charreau E.H., Sanjuan N., and Pasqualini C.D. Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors. J Natl Cancer Inst 79 (1987) 1341-1350
33. Kaunitz A.M. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. J Reprod Med 41 suppl 5 (1996) 419-427